Vaccine Development Through R&D Partnerships
Vaxiva will develop novel vaccine products via partnerships with:
(1) Established biopharmaceutical companies
(2) Japanese academic research Groups
(3) Established vaccine manufacturers
More specific information on Vaxiva’s current and anticipated R&D partnerships will be available here soon. Please contact Vaxiva directly for further information: info@vaxiva.com